Clinical trial
Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee
NCT00137410 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00137410 |
|---|---|
| Title | Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee |
| Official title | Protocol For A Multicentre, Double Blind, Parallel Group Pilot Study To Compare Celecoxib Long Term Vs Celecoxib Short Term Therapy In Treatment And Prevention Of New Flare In Patients With Osteoarthritis Of The Knee |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | Celebrex |
| Enrollment | 200 |
| Start date | Nov 1, 2002 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Aug 29, 2005 |
| Last update posted | Jun 10, 2008 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: